ELTX
Elicio Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.41
−3.60%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-81.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | Nissenson Allen · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | Ashe Carol Gail · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | ADAMS JULIAN · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | Venkatesan Jay · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | WILSON KAREN J · director | A-Award | 21,750 | $2.70 |
| Sep 2, 2026 | RUFFOLO ROBERT R · director | A-Award | 21,750 | $2.70 |
| Jul 17, 2026 | Haqq Christopher · officer: See Remarks | A-Award | 64,643 | $3.20 |
| Jul 17, 2026 | Connelly Robert · director, officer: CEO, President and Director | A-Award | 186,944 | $3.20 |
| Jul 17, 2026 | Shah Preetam · officer: See Remarks | A-Award | 60,833 | $3.20 |
| Jul 17, 2026 | DeMuth Peter · officer: Chief Scientific Officer | A-Award | 52,832 | $3.20 |
| Feb 3, 2026 | Connelly Robert · director, officer: CEO, President and Director | A-Award | 147,200 | $8.10 |
| Feb 3, 2026 | Connelly Robert · director, officer: CEO, President and Director | A-Award | 73,600 | $0.00 |
| Feb 3, 2026 | Shah Preetam · officer: See Remarks | A-Award | 47,900 | $8.10 |
| Feb 3, 2026 | Shah Preetam · officer: See Remarks | A-Award | 24,000 | $0.00 |
| Feb 3, 2026 | DeMuth Peter · officer: Chief Scientific Officer | A-Award | 41,600 | $8.10 |
| Feb 3, 2026 | DeMuth Peter · officer: Chief Scientific Officer | A-Award | 20,800 | $0.00 |
| Feb 3, 2026 | Haqq Christopher · officer: See Remarks | A-Award | 25,400 | $0.00 |
| Feb 3, 2026 | Haqq Christopher · officer: See Remarks | A-Award | 50,900 | $8.10 |
| Dec 10, 2025 | DeMuth Peter · officer: Chief Scientific Officer | M-Exempt | 362 | $4.41 |
| Jun 4, 2025 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 103,225 | $7.75 |
| May 20, 2025 | RUFFOLO ROBERT R · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Chudnovsky Yekaterina · director, 10 percent owner: | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Ashe Carol Gail · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Nissenson Allen · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | Venkatesan Jay · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | ADAMS JULIAN · director | A-Award | 7,900 | $5.84 |
| May 20, 2025 | WILSON KAREN J · director | A-Award | 7,900 | $5.84 |
| Apr 16, 2025 | Shah Preetam · officer: See Remarks | A-Award | 191,624 | $4.98 |
| Feb 4, 2025 | Haqq Christopher · officer: See Remarks | A-Award | 44,000 | $8.92 |
Institutional positioning
13F filings over the trailing two quarters
New 19Increased 15Reduced 7Sold out 48
| Filer | Action | Shares | Filed |
|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | Unchanged | 630,915 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 518,638 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 373,804 | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 244,814 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 149,200 | Sep 2, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 135,164 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 121,631 | May 14, 2026 |
| JANE STREET GROUP, LLC | New Position | 115,600 | May 12, 2026 |
| MILLENNIUM MANAGEMENT LLC | New Position | 92,762 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 78,078 | May 15, 2026 |
| MARSHALL WACE, LLP | Reduced | 74,512 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 69,189 | May 8, 2026 |
| NORTHERN TRUST CORP | Increased | 59,734 | May 14, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 57,818 | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Unchanged | 56,442 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 2, 2026